Association between the use of avilamycin for growth promotion and the occurrence of resistance among Enterococcus faecium from broilers: Epidemiological study and changes over time

Microbial Drug Resistance

Volumn 6, Issue 1, 2000, Pages 71-75

  Aarestrup, Frank Møller ^a   Bager, Flemming ^a   Andersen, Jens Strodl ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AVILAMYCIN; GROWTH PROMOTOR; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CHICKEN; CONTROLLED STUDY; DENMARK; ENTEROCOCCUS FAECIUM; FECES ANALYSIS; NONHUMAN; POULTRY; PRIORITY JOURNAL;

ANIMALIA; BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECIUM; GALLUS GALLUS;

EID: 0034090204     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2000.6.71     Document Type: Article

References (19)

1. Aarestrup, F.M. 1998. Association between decreased susceptibility to a new antibiotic for treatment of human diseases, everninomycin (SCH 27899), and resistance to ah antibiotic used for growth promotion in animals, avilamycin. Microb. Drug Resist. 4:137-141.
2. Aarestrup, F.M., F. Bager, M. Madsen, N.E. Jensen, A. Meyling, and H.C. Wegener. 1998. Surveillance of antimicrobial resistance in bacteria isolated from food animals to antimicrobialgrowth promoters and related therapeutic agents in Denmark. APMIS 106:606-622.
3. Aarstrup, F.M., and B. Carsterisen. 1998. Effect of tylosin used as a growth promoter on the occurrence of macrolide resistant enterococci and staphylococci in pigs. Microb. Drug Resist. 4:307-312.
4. Aarestrup, F.M. 1999. Association between the consumption of antimicrobial agents in animal husbandry and the occurrence of resistant bacteria among food animals. Int. J. Antimicrob. Agents 12:279-285.
5. Bager, F., M. Madsen, J. Christensen, and F.M. Aarestrup. 1997. Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms. Prev. Vet. Med. 31:95-112.
6. Bager, F., F.M. Aarestrup, M. Madsen, and H.C. Wegener. 1999. Levels of glycopeptide resistant E. faecium in broilers and pigs following ban on the use of avoparcin. Microb. Drug Resist. 5:53-56.
7. Bonilla, H.F., M.J. Zervos, and C.A. Kauffman. 1996. Long-term survival of vancomycin-resistant Enterococcus faecium on a contaminated surface. Infect. Control Hosp. Epidemiol. 17:770-771.
8. Brown, D.J., J.E. Olsen, and M. Bisgaard. 1992. Salmonella enterica: infection, cross infection and persistence within the environment of a broiler parent stock unit in Denmark. Zentralbl. Bakteriol. 277:129-138.
9. Donner, A. 1993. The comparison of proportions in the presence of litter effects. Prev. Vet. Med. 18:17-26.
10. ELANCO. 1999. Avilamycin (Maxus®) - The Science. ELANCO Animal Health, Eli Lilly and Company Limited, Hampshire, United Kingdom.
11. Gootz, T.D. 1990. Discovery and development of new antimicrobial agents. Clin. Microbiol. Rev. 3:13-31.
12. Jay, J.M. 1978. Modern Food Microbiology, 2nd ed. Van Nostrand Reinhold, New York, pp. 299-302.
13. Klare, I., D. Badstubner, C. Konstabel, G. Bohme, H. Claus, and W. Witte. 1999. Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparci usage in animal husbandry. Microb. Drug Resist. 5:45-52.
14. Pantosti, A., M. Del Grosso, S. Tagliabue, A. Macri, and A. Caprioli. 1999. Decrease of vancomycin-resistant enterococci in poultry meat after avoparcin ban. Lancet 354:741-742.
15. Smith, H.W., and W.E. Crabb. 1957. The effect of the continuous administration of diets containing low levels of tetracyclines on the incidence of drug-resistant Bacterium coli in the faeces of pigs and chickens: The sensitivity of the Bact. coli to other chemotherapeutic agents. Vet. Rec. 69:24-30.
16. Spera, R.V., and B.F. Farber. 1994. Multidrug-resistant Enterococcus faecium. An unbeatable nosocomial pathogen. Drugs 48:678-688.
17. Travis, J. 1994. Reviving the antibiotic miracle? Science 264:360-362.
18. van Leeuwen, WJ., J. van Embden, P. Guinee, E.H. Kampelmacher, A. Manten, M. van Schothorst, and C.E. Voogd. 1979. Decrease of drug resistance in Salmonella in the Netherlands. Antimicrob. Agents Chemother. 16:237-239.
19. Wendt, C., B. Wiesenthal, E. Dietz, and H. Ruden. 1998. Survival of vancomycin-resistant and vancomycin-susceptible enterococci on dry surfaces. J. Clin. Microbiol. 36:3734-3736.